Literature DB >> 21497279

Increased risks of upper tract urothelial carcinoma in male and female chinese herbalists.

Hsiao-Yu Yang1, Jung-Der Wang, Tsai-Chang Lo, Pau-Chung Chen.   

Abstract

BACKGROUND/
PURPOSE: It has been shown that herbs that contain aristolochic acid induce urological cancer. Chinese herbalists have easy access to such herbs. Our previous mortality study has shown a significantly increased risk of urological cancer in female but not male herbalists. To re-examine this risk in male herbalists, the incidence of urological cancer was analyzed.
METHODS: We enrolled all 6550 Chinese herbalists in Taiwan registered during 1985-2000, and we retrospectively followed the development of cancer until 2001 by analysis of data collected from the Taiwan Cancer Registry. Standardized incidence ratios (SIRs) were calculated for urological cancers in herbalists and compared with those for the general population in Taiwan.
RESULTS: There were 30 newly diagnosed cases of urological cancer and most of them were transitional cell carcinoma (93.1%). The mean age at diagnosis for urothelial carcinoma was 51.6 years, and 51.9% were in the upper urinary tract. After adjustment for age and sex, the SIR for all urological cancers was 3.51 [(95% confidence interval (CI): 2.37-5.01]. When stratified by location, the SIRs for kidney and upper urinary tract cancers and bladder cancer were 4.24 (95% CI: 2.47-6.80) and 2.86 (95% CI: 1.52-4.89), respectively. When analyzed by sex, the SIRs for all urological cancers, kidney and upper urinary tract cancers, and bladder cancer were also significantly increased in male herbalists.
CONCLUSION: The significant risk of urothelial carcinoma noted in male herbalists increases our suspicion that this is an occupational disease that renders regular health assessment of herbalists an urgent necessity.
Copyright © 2011 Formosan Medical Association & Elsevier. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21497279     DOI: 10.1016/S0929-6646(11)60026-0

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  7 in total

1.  Aristolochic acid-containing Chinese herbal medicine and upper urinary tract urothelial carcinoma in Taiwan: a narrative review.

Authors:  Kathleen G Dickman; Chung-Hsin Chen; Arthur P Grollman; Yeong-Shiau Pu
Journal:  World J Urol       Date:  2022-07-22       Impact factor: 3.661

Review 2.  Aristolochic acid-associated cancers: a public health risk in need of global action.

Authors:  Samrat Das; Shefali Thakur; Michael Korenjak; Viktoriya S Sidorenko; Felicia Fei-Lei Chung; Jiri Zavadil
Journal:  Nat Rev Cancer       Date:  2022-07-19       Impact factor: 69.800

3.  A population-based study on the association between urinary calculi and kidney cancer.

Authors:  Shiu-Dong Chung; Shih-Ping Liu; Herng-Ching Lin
Journal:  Can Urol Assoc J       Date:  2013 Nov-Dec       Impact factor: 1.862

Review 4.  Chinese herbs containing aristolochic acid associated with renal failure and urothelial carcinoma: a review from epidemiologic observations to causal inference.

Authors:  Hsiao-Yu Yang; Pau-Chung Chen; Jung-Der Wang
Journal:  Biomed Res Int       Date:  2014-08-27       Impact factor: 3.411

5.  New Users of Herbal Medicine Containing Aristolochic Acids and the Risk of Dementia in the Elderly: A Nationwide, Population-Based Study in Taiwan.

Authors:  Wu-Chien Chien; Pei-Kwei Tsay; Nian-Sheng Tzeng; Yueh-Er Chiou; Chi-Hsiang Chung; Hsin-An Chang; Yu-Chen Kao
Journal:  Neuropsychiatr Dis Treat       Date:  2020-06-12       Impact factor: 2.570

6.  Aristolochic acid mutational signature defines the low-risk subtype in upper tract urothelial carcinoma.

Authors:  Huan Lu; Yuan Liang; Bao Guan; Yue Shi; Yanqing Gong; Juan Li; Wenwen Kong; Jin Liu; Dong Fang; Libo Liu; Qun He; Muhammad Shakeel; Xuesong Li; Liqun Zhou; Weimin Ci
Journal:  Theranostics       Date:  2020-03-04       Impact factor: 11.556

7.  Reduction in the Incidence of Urological Cancers after the Ban on Chinese Herbal Products Containing Aristolochic Acid: An Interrupted Time-Series Analysis.

Authors:  Jing-Rong Jhuang; Chun-Ju Chiang; Shih-Yung Su; Ya-Wen Yang; Wen-Chung Lee
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.